Cantitate/Preț
Produs

Hematopathology: Genomic Mechanisms of Neoplastic Diseases: Molecular and Translational Medicine

Editat de Domnita Crisan
en Limba Engleză Paperback – 6 noi 2012
Hematopathology: Genomic Mechanisms of Neoplastic Diseases will keep physicians abreast of the rapid and complex changes in genomic medicine, as exemplified by the molecular pathology of hematologic malignancies. This timely volume will update physicians on the complexities of genomic lesions, as well as offer an integrated framework encompassing molecular diagnosis, the new WHO classification of hematologic  neoplasms with focus on molecular pathology, prognostic value of molecular tests, and molecular monitoring of response to gene-targeted therapy. As such, it will be of great value to hematologists, oncologists, pathologists, internal medicine and pediatric specialists, as well as bioscientific staff and laboratorians in private hospitals and academic institutions.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 138523 lei  6-8 săpt.
  Humana Press Inc. – 6 noi 2012 138523 lei  6-8 săpt.
Hardback (1) 139865 lei  6-8 săpt.
  Humana Press Inc. – 21 sep 2010 139865 lei  6-8 săpt.

Din seria Molecular and Translational Medicine

Preț: 138523 lei

Preț vechi: 145815 lei
-5% Nou

Puncte Express: 2078

Preț estimativ în valută:
26515 27834$ 21903£

Carte tipărită la comandă

Livrare economică 30 ianuarie-13 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781617797088
ISBN-10: 1617797081
Pagini: 372
Ilustrații: XII, 360 p.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.52 kg
Ediția:2011
Editura: Humana Press Inc.
Colecția Humana
Seria Molecular and Translational Medicine

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

Chapter 1: Molecular techniques used in Hematopathology.- Chapter 2: Cytogenetics techniques used in Hematopathology.- Chapter 3: The molecular component of the new WHO classification of hematologic malignancies.- Chapter 4: Molecular pathology of pediatric acute leukemias.- Chapter 5: Molecular pathology of adult acute leukemias.- Chapter 6: Molecular pathology of lymphomas.- Chapter 7: Molecular pathology of chronic myeloproliferative neoplasms.- Chapter 8: Molecular pathology of CLL.- Chapter 9: Targeted therapy in hematologic malignancies.- Chapter 10: MicroRNAs in hematologic malignancies.

Recenzii

From the reviews:
“This book addresses the current knowledge of genomics as applied to the pathogenesis, diagnosis, prognosis, monitoring, and targeted therapy of hematologic malignancies. … the book is intended for molecular pathologists, hematopathologists, general surgical pathologists, pathology residents, and hematopathology fellows. … This is a good, quick reference for practicing pathologists dealing with hematologic specimens. … the book is quite easy to read, as it is written primarily for practicing pathologists. … book is certainly suitable for departmental libraries and the shelves of practicing pathologists.” (Anamarija M. Perry, Doody’s Review Service, April, 2011) 
“It gives basic information about the techniques available and a detailed overview of molecular changes in particular hematological malignant diseases. … Anybody working in this field, irrespective if in research, laboratory diagnostics or clinical treatment, will welcome this book, because the relevant information can be found here quickly and easily. … recommended for residents, fellows in training as well as for specialist looking for information from the field of interest they do not deal with daily. It should not be missing in any hematological department.” (M. Hrubiško, Neoplasma, March, 2011)

Textul de pe ultima copertă

Hematopathology: Genomic Mechanisms of Neoplastic Diseases will keep physicians abreast of the rapid and complex changes in genomic medicine, as exemplified by the molecular pathology of hematologic malignancies. This timely volume will update physicians on the complexities of genomic lesions, as well as offer an integrated framework encompassing molecular diagnosis, the new WHO classification of hematologic  neoplasms with focus on molecular pathology, prognostic value of molecular tests, and molecular monitoring of response to gene-targeted therapy. As such, it will be of great value to hematologists, oncologists, pathologists, internal medicine and pediatric specialists, as well as bioscientific staff and laboratorians in private hospitals and academic institutions.

Caracteristici

Prognostic value of molecular tests Offers an integrated framework encompassing molecular diagnosis Written by experts in the field Includes supplementary material: sn.pub/extras